Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui LaBarre Michael J.. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan LaBarre Michael J. telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti Tajuk Pegangan Terkini Dilaporkan
US:HALO / Halozyme Therapeutics, Inc. SVP, CHIEF TECHNICAL OFFICER 173,756
Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh LaBarre Michael J.. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam HALO / Halozyme Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam HALO / Halozyme Therapeutics, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Maks
Harga pada
Maks
Maks
Keuntungan ($)
Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Jualan Orang Dalam HALO / Halozyme Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam HALO / Halozyme Therapeutics, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan
Harga
Dilaporkan
Saham
Dilaraskan
Harga
Dilaraskan
Asas Kos Hari ke
Min
Harga pada
Min
Kerugian Maks
Dielakkan ($)
Kerugian Maks
Dielakkan (%)
2023-02-16 HALO LaBarre Michael J. 2,878 49.2600 2,878 49.2600 141,770 81 30.2800 -54,624 -38.53

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh LaBarre Michael J. seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah
Saham
harga
Tran
Nilai
Baki
Nilai
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 173,756 -0.06 58.74 -5,874 10,206,427
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,597 173,856 -0.91 58.25 -93,028 10,127,460
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 175,453 -0.34 58.65 -35,189 10,289,968
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,400 176,053 -5.07 58.09 -546,055 10,227,095
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -700 185,453 -0.38 58.67 -41,069 10,880,528
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,300 186,153 -4.76 58.01 -539,465 10,798,177
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,410 195,453 -1.22 57.75 -139,178 11,287,411
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,747 197,863 2.46
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,164 193,116 -1.11 58.29 -126,140 11,256,732
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,263 195,280 2.23
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,103 191,017 -1.60 58.29 -180,874 11,134,381
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 194,120 3.25
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -8,721 188,008 -4.43 58.29 -508,347 10,958,986
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 20,891 196,729 11.88
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,304 175,838 -0.74 58.29 -76,010 10,249,597
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 177,142 1.95
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 173,756 -5.44 53.26 -532,590 9,254,071
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 19.98 199,800 3,671,445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -77 173,756 -0.04 54.24 -4,177 9,425,394
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,923 173,833 -5.40 53.74 -533,292 9,342,307
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 4,491 183,756 2.51 19.98 89,730 3,671,445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 5,509 179,265 3.17 16.65 91,725 2,984,762
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,037 173,756 -1.16 62.58 -127,477 10,873,824
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,963 175,793 -4.33 61.89 -492,838 10,880,005
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 16.65 166,500 3,059,537
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 173,756 -5.44 62.88 -628,780 10,925,430
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 16.65 166,500 3,059,537
2024-08-27 2024-08-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,580 173,756 3.32 18.41 102,728 3,198,848
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 168,176 -0.06 62.34 -6,234 10,484,092
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,900 168,276 -5.56 61.74 -611,236 10,389,529
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 16.65 166,500 2,966,630
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 61.06 -610,550 10,267,986
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 16.65 166,500 2,966,630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 55.12 -551,150 9,269,020
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,285 178,176 4.88 16.65 137,945 2,966,630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,715 169,891 1.02 8.11 13,909 1,377,816
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5,291 168,176 -3.05 55.26 -292,407 9,294,247
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,709 173,467 -2.64 54.46 -256,466 9,447,533
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 49.43 -494,260 8,312,267
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 45.38 -453,840 7,632,500
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 45.16 -451,640 7,595,501
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 38.49 -384,890 6,472,926
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 38.35 -383,500 6,449,550
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2,890 168,176 1.75 8.11 23,438 1,363,907
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 292 165,286 0.18 16.78 4,900 2,773,499
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,436 164,994 5.39 12.07 101,823 1,991,478
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 156,558 -6.00 42.27 -422,730 6,618,176
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 3,551 166,558 2.18 8.11 28,799 1,350,785
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 6,449 163,007 4.12 12.07 77,839 1,967,494
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 156,558 -6.00 41.64 -416,370 6,518,605
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 166,558 6.39 12.07 120,700 2,010,355
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,471 156,558 -4.55 39.54 -295,418 6,190,616
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 7,471 164,029 4.77 8.11 60,590 1,330,275
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,529 156,558 -1.59 39.56 -100,045 6,193,278
2024-02-28 2024-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 159,087 -5.91 39.95 -399,460 6,354,889
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,160 169,087 -1.26 36.10 -77,976 6,104,041
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,264 171,247 2.55
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,097 166,983 -1.82 36.10 -111,802 6,028,086
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 170,080 3.73
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,832 163,968 -2.28 35.91 -137,607 5,888,091
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8,479 167,800 5.32
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,208 159,321 -0.75 35.91 -43,379 5,721,217
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 160,529 2.15
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,901 157,143 -1.81 35.49 -102,956 5,577,005
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 160,044 5.35
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.00 -360,000 5,468,796
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.00 -360,000 5,468,796
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 40.39 -403,940 6,136,293
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -643 151,911 -0.42 40.46 -26,019 6,147,079
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,357 152,554 -5.78 39.58 -370,303 6,037,325
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,467 161,911 0.91 12.07 17,707 1,954,266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,533 160,444 5.62 13.81 117,841 2,215,732
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 39.79 -397,880 6,044,235
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 13.81 138,100 2,235,991
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,708 151,911 -1.11 39.08 -66,747 5,936,530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,708 153,619 1.12 16.78 28,660 2,577,727
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,292 151,911 -5.18 39.08 -324,043 5,936,530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,292 160,203 5.46 13.81 114,513 2,212,403
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.52 -365,200 5,547,790
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 19.98 199,800 3,234,982
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 39.10 -390,980 5,939,416
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 19.98 199,800 3,234,982
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,075 151,911 -5.05 42.41 -342,437 6,442,090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,075 159,986 5.32 19.98 161,338 3,196,520
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,925 151,911 -1.25 42.41 -81,633 6,442,090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,925 153,836 1.27 18.41 35,439 2,832,121
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2,825 151,911 1.89 8.11 22,911 1,231,998
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,175 149,086 5.06 13.81 99,087 2,058,878
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 40.43 -404,300 5,737,462
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 36.00 -360,000 5,108,796
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,984 141,911 -2.06 49.55 -147,854 7,031,548
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 2,984 144,895 2.10 18.41 54,935 2,667,517
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 36.00 -360,000 5,108,796
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,984 138,927 -2.10 49.55 -147,854 6,883,694
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,016 141,911 -4.71 49.55 -347,629 7,031,406
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -2,878 148,927 -1.90 49.26 -141,770 7,336,144
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 151,805 4.20
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,170 145,693 -0.80 49.20 -57,564 7,168,096
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 146,863 2.36
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 143,477 -6.52 48.39 -483,940 6,943,426
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 153,477 -1.74 48.92 -133,307 7,508,095
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 156,202 5.31
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,951 148,319 -1.95 48.92 -144,363 7,255,765
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 151,270 5.68
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,122 143,137 -0.78 50.93 -57,139 7,289,395
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,878 144,259 -5.80 50.40 -447,451 7,270,654
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5,065 153,137 -3.20 58.66 -297,133 8,983,629
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,935 158,202 -3.03 58.67 -289,541 9,281,870
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3,115 163,137 -1.87 54.14 -168,643 8,832,074
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 166,252 0.00 54.61 -437 9,079,022
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6,877 166,260 -3.97 54.12 -372,183 8,997,991
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 24,448 24,448
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 74,777 74,777
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -3,386 10,158 -25.00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,170 173,137 -0.67 34.43 -40,283 5,961,107
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 174,307 1.98
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,771 0 -100.00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,995 170,921 -1.15 33.64 -67,112 5,749,782
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,771 172,916 3.45
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 7,883 -50.00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 167,145 -1.60 34.20 -93,195 5,716,359
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 169,870 4.87
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,133 16,266 -33.33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,992 161,987 -1.81 34.94 -104,540 5,659,826
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 164,979 5.19
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -8,050 0 -100.00
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,050 156,846 5.41 13.10 105,455 2,054,683
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -29,450 8,050 -78.53
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -29,450 148,796 -16.52 39.93 -1,175,968 5,941,573
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 29,450 178,246 19.79 13.10 385,795 2,335,023
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -14,685 0 -100.00
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 14,685 148,796 10.95 6.55 96,187 974,614
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -40,315 14,685 -73.30
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -40,315 134,111 -23.11 45.70 -1,842,315 6,128,604
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 40,315 174,426 30.06 6.55 264,063 1,142,490
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -11,311 0 -100.00
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,311 134,111 9.21 11.29 127,701 1,514,113
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -28,689 11,311 -71.72
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18,994 122,800 -13.40 42.79 -812,829 5,255,103
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,695 141,794 -6.40 42.10 -408,208 5,970,236
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28,689 151,489 23.36 11.29 323,899 1,710,311
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6,530 122,800 -5.05 46.26 -302,061 5,680,409
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11,794 129,330 -8.36 45.56 -537,303 5,891,926
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,803 0 -100.00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,364 141,124 -3.00 48.69 -212,483 6,871,328
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,803 145,488 6.44
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 13,544 13,544
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 23,311 23,311
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,771 5,771 -50.00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,272 136,685 -1.64 49.84 -113,236 6,812,380
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,771 138,957 4.33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 15,766 -33.33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 133,186 -2.00 49.84 -135,814 6,637,990
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 135,911 6.16
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,134 24,399 -25.00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,906 128,028 -2.22 50.60 -147,044 6,478,217
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,134 130,934 6.62
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 122,800 -0.49 43.25 -25,951 5,311,346
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11,400 123,400 -8.46 42.54 -484,967 5,249,559
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,889 134,800 -5.53 39.04 -307,955 5,262,053
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,111 142,689 -2.80 38.24 -157,221 5,456,998
2020-10-20 2020-10-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 146,800 -7.56 30.43 -365,148 4,466,977
2020-09-21 2020-09-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 158,800 -7.03 26.91 -322,884 4,272,832
2020-08-20 2020-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 170,800 -6.56 28.30 -339,564 4,833,128
2020-07-20 2020-07-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 182,800 -6.16 29.01 -348,072 5,302,297
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -18,613 0 -100.00
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 18,613 194,800 10.56 7.14 132,897 1,390,872
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -21,387 18,613 -53.47
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21,387 176,187 -10.82 23.80 -509,075 4,193,779
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21,387 197,574 12.14 7.14 152,703 1,410,678
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,803 8,803 -50.00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,044 176,187 -1.70 21.83 -66,451 3,846,162
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,803 179,231 5.17
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,772 11,542 -33.34
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,995 170,428 -1.16 21.10 -42,094 3,596,031
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,772 172,423 3.46
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 23,649 -25.00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 166,651 -1.61 20.00 -54,500 3,333,020
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 169,376 4.88
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 32,533 32,533
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 69,174 69,174
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,559 0 -100.00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,289 161,493 -2.59 19.21 -82,392 3,102,281
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,559 165,782 7.49
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)